<?xml version="1.0" encoding="UTF-8"?>
<p>In addition to use in infants, MTBVAC is being assessed for use in adolescents and adults previously vaccinated with BCG. Preclinical studies of revaccination of guinea pigs with MTBVAC have demonstrated improved protection compared to that conferred by BCG 
 <sup>
  <xref rid="ref-42" ref-type="bibr">42</xref>
 </sup>. Initiation of a phase 1b-2a, double blind, randomized, BCG-controlled, dose-escalation safety and immunogenicity study in 120 healthy South African adults, ages 18â€“50 years, with and without LTBI is being planned (NCT02933281).
</p>
